Everybody Dance Now – Moving Medicine
“Moving Medicine is the single most important advance in therapeutics in my 50 years in medicine. The benefit to harm ratio is outstandingly favourable and every drug or psychological prescription for a long-term condition should be partnered by a Moving Medicine prescription of activity.” Sir Muir Gray Kt CBE DSc MD
Gabapentin & Pregabalin – to be Controlled Drugs in 2019
The Home Office has announced plans to classify both gabapentin and pregabalin as Class C controlled drugs in April 2019. The decision to apply Misuse of Drugs act controls to gabapentin and pregabalin is based on advice from the Advisory Council on the Misuse of Drugs – in response to concerns over medicinal misuse, illegal diversion of the drugs and Continue Reading »
Jext Adrenaline Auto-Injectors – Extended Use By Dates
Adrenaline 150microgram Auto-injectors – Supply Controls
The Department of Health & Social Care (DHSC) has put in place a Dispenser Validation process for all prescriptions for 150 microgram adrenaline auto-injectors. The validation process is designed to ensure that all children weighing 25Kg or less have access to two 150 microgram adrenaline auto-injectors and that at least one of these is in-date. DHSC has stated: Continue Reading »
NHS England Press Release – Adalimumab Patent Expiry
NHS England have issued a Press Release announcing that the NHS is set “to save £150 million by switching to new versions of most costly drug.” NHS Hospitals have been asked “to ensure they are ready to realise savings of up to £150 million a year to reinvest in frontline care after the patent on the NHS’s most costly Continue Reading »